Tonix Pharmaceuticals (TNXP) News Today → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free TNXP Stock Alerts $0.20 +0.02 (+11.29%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 17 at 1:25 AM | seekingalpha.comTNXP Tonix Pharmaceuticals Holding Corp.May 15, 2024 | globenewswire.comTonix Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company ShowcaseMay 14, 2024 | finanznachrichten.deTonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational HighlightsMay 13, 2024 | globenewswire.comTonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational HighlightsMay 13, 2024 | americanbankingnews.comTonix Pharmaceuticals (NASDAQ:TNXP) Receives New Coverage from Analysts at StockNews.comApril 29, 2024 | msn.comTNXP: Approval of First New Fibromyalgia Drug in 15 Years Possible in 2025…April 24, 2024 | globenewswire.comTonix Pharmaceuticals Announces Presentation at Planet MicroCap ShowcaseApril 17, 2024 | msn.comTonix Pharmaceuticals Holding (TNXP) Price Target Decreased by 37.78% to 3.57April 9, 2024 | investorplace.com3 Biotech Stocks to Dump Before They Go to ZeroApril 1, 2024 | globenewswire.comTonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational HighlightsApril 1, 2024 | msn.comTonix Pharmaceuticals Stock (TNXP) Hits A New All-Time Low: What's Going On?March 30, 2024 | benzinga.comLatest News for Tonix Pharmaceuticals Stock (NASDAQ:TNXP)March 28, 2024 | benzinga.comWhy Tonix Pharmaceuticals Stock (TNXP) Is Getting ObliteratedMarch 28, 2024 | globenewswire.comTonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct OfferingMarch 25, 2024 | markets.businessinsider.comTonix Pharma's TNX-2900 Gets Rare Pediatric Disease Designation For Prader-Willi SyndromeMarch 25, 2024 | globenewswire.comTonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi SyndromeMarch 24, 2024 | investorplace.com3 Mind-Blowing Stocks That Could Turn $1,000 Into $1 MillionMarch 22, 2024 | morningstar.comTonix Pharmaceuticals Holding CorpMarch 21, 2024 | finance.yahoo.comTonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Oxytocin Analogues at the American Chemistry Society (ACS) Spring 2024 MeetingMarch 20, 2024 | msn.comTonix picks CMOs for potential launch of fibromyalgia drugMarch 19, 2024 | globenewswire.comTonix Pharmaceuticals Announces Transition to Fully Integrated Biopharmaceutical Company Expected on April 1, 2024March 12, 2024 | finance.yahoo.comTNXP: Tonmya™ May Launch Alongside Another New Fibromyalgia Treatment…March 12, 2024 | globenewswire.comTonix Pharmaceuticals Announces Presentation at BIO-Europe SpringMarch 11, 2024 | finance.yahoo.comTonix Pharmaceuticals Reports Improvement in “Brain Fog,” in Fibromyalgia Patients Treated with Tonmya™ in RESILIENT, an NDA-Enabling Phase 3 Clinical Trial, at the 6th International Congress on Controversies in FibromyalgiaMarch 7, 2024 | globenewswire.comTonix Pharmaceuticals Announces Publication in Psychiatry Research Showing Activity of Bedtime TNX-102 SL on PTSD Symptoms and Sleep Quality in Military-Related PTSD at Four Weeks of TherapyMarch 6, 2024 | finance.yahoo.comTonix Pharmaceuticals Selects EVERSANA® to Support Launch Strategy and Commercialization Planning of Tonmya™ for the Management of FibromyalgiaMarch 5, 2024 | finance.yahoo.comTonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (Fc-modified humanized anti-CD40L mAb) Supports Monthly i.v. Dosing in HumansFebruary 29, 2024 | msn.comDawson James Initiates Coverage of Tonix Pharmaceuticals Holding (TNXP) with Buy RecommendationFebruary 28, 2024 | finance.yahoo.comTonix Pharmaceuticals drug TNX-102 SL gets FDA ok for US Department of Defense funded trialFebruary 28, 2024 | finance.yahoo.comTonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized anti-CD40L mAb) in Healthy VolunteersFebruary 27, 2024 | markets.businessinsider.comTonix Pharma Plans Regulatory Filings For Tonmya In Japan, China, US; Stock UpFebruary 27, 2024 | finance.yahoo.comTonix Pharmaceuticals Announces Positive Results from Clinical Pharmacokinetic Bridging Study of Tonmya™ to Support Development and Partnering in Japan and ChinaFebruary 26, 2024 | finance.yahoo.comNew Drug Study Shows Improving Sleep Quality Can Relieve Fibromyalgia PainFebruary 25, 2024 | investorplace.com3 Top Penny Stocks for 5,000% Upside in 2024 and BeyondFebruary 23, 2024 | finance.yahoo.comNew to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Business Televised SeriesFebruary 23, 2024 | proactiveinvestors.comTonix Pharmaceuticals' Fibromyalgia Trial Shows Promising Results in Webinar PresentationFebruary 20, 2024 | proactiveinvestors.comTonix Pharmaceuticals drug TNX-102 SL gets FDA ok for US Department of Defence funded trialFebruary 20, 2024 | finance.yahoo.comTonix Pharmaceuticals to Participate in the 2024 BIO CEO & Investor ConferenceFebruary 20, 2024 | globenewswire.comTonix Pharmaceuticals to Participate in the 2024 BIO CEO & Investor ConferenceFebruary 17, 2024 | finance.yahoo.comACXP Mar 2024 3.000 putFebruary 16, 2024 | finance.yahoo.comNew to The Street Airs Episode 556 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network Monday, February 19, 2024, at 10:30 PM PTFebruary 15, 2024 | finanznachrichten.deTonix Pharmaceuticals: Tonix Drug Shown To Relieve Pain in Fibromyalgia Without Risk of AddictionFebruary 15, 2024 | finance.yahoo.comTonix Drug Shown To Relieve Pain in Fibromyalgia Without Risk of AddictionFebruary 14, 2024 | finance.yahoo.comTonix Pharmaceuticals Hosted KOL Webinar on Positive Phase 3 Fibromyalgia Trial for Tonmya™, Plans to File NDA for FDA Approval in Second Half of 2024February 14, 2024 | globenewswire.comTonix Pharmaceuticals Hosted KOL Webinar on Positive Phase 3 Fibromyalgia Trial for Tonmya™, Plans to File NDA for FDA Approval in Second Half of 2024February 12, 2024 | msn.comTonix stock climbs 9% after FDA approves PTSD studyFebruary 9, 2024 | benzinga.comTonix Drug Shown To Relieve Pain in Fibromyalgia Without Getting Patients Addicted In Phase 3 TrialFebruary 2, 2024 | msn.comTonix Pharma Discloses COPCs Linked to Long COVID RiskFebruary 1, 2024 | msn.comTonix Pharma Examines COPCs Impact on Long COVID RisksJanuary 31, 2024 | finance.yahoo.comTonix Pharmaceuticals Announces Research Indicating Pre-Existing Fibromyalgia-Type Symptoms May Increase the Risk of Developing Long COVID Get Tonix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNXP and its competitors with MarketBeat's FREE daily newsletter. Email Address The Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm. Click here to access the Crypto Retirement Blueprint now. TNXP Media Mentions By Week TNXP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TNXP News Sentiment▼0.430.42▲Average Medical News Sentiment TNXP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TNXP Articles This Week▼62▲TNXP Articles Average Week Get Tonix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNXP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Vaxxinity News Cocrystal Pharma News Talphera News Aytu BioPharma News VBI Vaccines News Minerva Neurosciences News Vincerx Pharma News Indaptus Therapeutics News NeuroSense Therapeutics News Orgenesis News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TNXP) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm PressHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tonix Pharmaceuticals Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
